%PDF-1.4
%
36 0 obj
<>
endobj
33 0 obj
<>
endobj
92 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-09-13T14:07:42Z
2024-03-29T08:38:46-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T08:38:46-07:00
application/pdf
Heather
2003-947.oct
uuid:51da277c-1dd2-11b2-0a00-8808276d7200
uuid:51da277f-1dd2-11b2-0a00-b80000000000
endstream
endobj
22 0 obj
<>
endobj
23 0 obj
<>
endobj
37 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 12 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 14 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 16 0 R/Type/Page>>
endobj
102 0 obj
[106 0 R]
endobj
103 0 obj
<>stream
q
0 0 612 783 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6283 0.7779 -0.7779 0.6283 8.2321 49.765 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 783 m
0 783 l
f
q
-1 784 587 -785 re
W n
q
0 783.03 612 -783 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.1683 Tw 10 0 0 10 43 731.1616 Tm
(power to perform multivariable analyses examining inde-)Tj
0.24229 Tw 0 -1.2 TD
(pendent associations of clinical covariables with clinical)Tj
0.02499 Tw T*
(outcomes to make conclusions about causation. )Tj
0.0528 Tw 1.2 -1.2 Td
(BMD measurements are known to be predictive of frac-)Tj
0.16119 Tw -1.2 -1.2 Td
(ture risks. BMD testing of men and women with clinical)Tj
0.3517 Tw T*
(characteristics predisposing to osteoporosis is generally)Tj
0 Tw T*
(recommended)Tj
0 Tc 6.5 0 0 6.5 99.6382 662.4615 Tm
[(1)56.7 (1,12)]TJ
-0.00011 Tc 0.0136 Tw 10 0 0 10 113.8944 659.1616 Tm
(. In addition, spinal radiographs should be)Tj
0.2435 Tw -7.0894 -1.2 Td
(conducted to investigate vertebral fractures in men with)Tj
0.1573 Tw T*
(back pain, particularly in the setting of known secondary)Tj
0.3022 Tw T*
(causes of osteoporosis \(such as hypogonadism, cortico-)Tj
0.0132 Tw T*
(steroid use, excessive alcohol consumption, or other predis-)Tj
-0.0314 Tw T*
[(posing medical conditions\). )17.7 (T)35 (reatment is generally indicated)]TJ
-0.0264 Tw T*
(if one or more prevalent vertebral fractures are found in men)Tj
0.026 Tw T*
(or women, particularly if no major trauma causing the frac-)Tj
0.02499 Tw T*
(ture is identified. )Tj
/T1_2 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES )Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 50 529.1616 Tm
[(1.)-875.1 (Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a)]TJ
1.675 -1.25 Td
(worldwide projection. Osteoporos Int 1992;2:285-9.)Tj
-1.675 -1.25 Td
[(2.)-875.1 (De Laet CE, Pols HA. Fractures in the elderly: epidemiology and)]TJ
1.675 -1.25 Td
[(demography)64.8 (. Baillieres Best Pract Res Clin Endocrinol Metab)]TJ
0 Tc 0 Tw 0 -1.25 TD
(2000;14:171-9.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(3.)-875.1 (Diamond )17.7 (TH, )17.7 (Thornley SW)91.7 (, Sekel R, Smerdely P)110.7 (. Hip fractures in)]TJ
1.675 -1.25 Td
[(elderly men: prognostic factors and outcomes. Med J )54.8 (Aust)]TJ
0 Tc 0 Tw T*
(1997;167:412-5.)Tj
-0.00011 Tc 0.0249 Tw 31.325 34.171 Td
[(4.)-875.1 (Jackson SA, )17.6 (T)69.9 (enenhouse )54.7 (A, Robertson L. )17.6 (V)110.8 (ertebral fracture )]TJ
1.675 -1.25 Td
(definition from population-based data: preliminary results from the)Tj
T*
(Canadian Multicenter Osteoporosis Survey \(CaMos\). Osteoporos)Tj
T*
[(Int 2000;1)36.8 (1:680-7.)]TJ
-1.675 -1.25 Td
[(5.)-875.1 (Orwoll E, Ettinger M, )17.7 (W)79.9 (eiss S, et al. )54.8 (Alendronate for the treatment)]TJ
1.675 -1.25 Td
(of osteoporosis in men. N Engl J Med 2000;343:604-10. )Tj
-1.675 -1.25 Td
[(6.)-875.1 (Ringe JD, Orwoll E, Daifotis )54.8 (A, Lombardi )54.8 (A. )17.7 (T)35 (reatment of male)]TJ
1.675 -1.25 Td
(osteoporosis. Osteoporos Int 2002;13:195-9.)Tj
-1.675 -1.25 Td
[(7.)-875.1 (Ho )36.8 (YV)128.8 (, Frauman )54.8 (AG, )17.7 (Thompson )17.7 (W)91.8 (, Seeman E. Ef)17.7 (fects of )]TJ
1.675 -1.25 Td
(alendronate on bone mineral density in men with primary and)Tj
T*
[(secondary osteoporosis. Osteoporos Int 2000;1)36.8 (1:98-101.)]TJ
-1.675 -1.25 Td
[(8.)-875.1 (Kiebzak GM, Beinart GA, Perser K. )54.8 (Ambrose CG, Sif)17.7 (f SJ,)]TJ
1.675 -1.25 Td
(Heggeness MH. Undertreatment of osteoporosis in men with hip)Tj
T*
[(fracture. )54.8 (Arch Intern Med 2002;162:2217-22.)]TJ
-1.675 -1.25 Td
[(9.)-875.1 (Sebaldt RJ, )54.8 (Adachi JD. Canadian database of osteoporosis and)]TJ
1.675 -1.25 Td
[(osteopenia patients \(CANDOO\). Canadian Or)17.7 (ganization for the)]TJ
T*
(Advancement of Computers in Healthcare 1996;21:36-9. )Tj
-2.175 -1.25 Td
[(10.)-875.1 (Liu G, Peacock M, Eilam O, Dorulla G, Braunstein E, Johnston)]TJ
2.175 -1.25 Td
[(CC. Ef)17.7 (fect of osteoarthritis in the lumbar spine and hip on bone)]TJ
T*
(mineral density and diagnosis of osteoporosis in elderly men and)Tj
T*
(women. Osteoporos Int 1997:7:564-9.)Tj
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Khan )54.8 (AA, Brown JP)110.8 (, Kendler DL, et al. )17.7 (The 2002 Canadian bone)]TJ
2.1381 -1.25 Td
(densitometry recommendations: take-home messages. CMAJ)Tj
0 Tc 0 Tw T*
[(2002;167:1)36.9 (141-5.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(12.)-875.1 (Cummings SR, Bates D, Black DM. Clinical use of bone )]TJ
2.175 -1.25 Td
[(densitometry: Scientific review)64.8 (. JAMA)-220.2 (2002;288:1889-97.)]TJ
ET
0 0 0 1 K
43 72 m
547 72 l
S
BT
/T1_3 1 Tf
8 0 0 8 43.5 53.9844 Tm
[(Sawka, et al: OP)-257.3 (in Canadian men)]TJ
0 Tc 0 Tw 60.9375 -0.0313 Td
(1995)Tj
ET
0 0 0 0 k
/GS0 gs
97.22 76.74 396.48 -10.83 re
f*
0.5 w
97.22 76.74 396.48 -10.83 re
S
Q
Q
q
0 0 612 783 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
110.368 69 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 8 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
16 0 obj
<>stream
8;Z\7d14&:#iu#8OPa3BE*t!Bg:H[&CXt$g*ZQ;?b__sD$L0di@DUKeINsU?rj^sT
i4DIr/3u"SIlc_,CfK6\=BX6D7f7I1,53:jIRLq!Sn6VQ.s$c?KRU)I8BO?A^>?@M
j.&S/q+Ngf9aW#5gbUjG*p.o@,;I?E8[@*&:/G4AD&ejW9Tj;DOYOi*NYPAgbHZ-T
9]]SBCX?Eu/nM7T6/@Df:T<^nA:Hoi3e=Ep6_UDhRpe\@22++$DR-h6l^l*.dbBb/
Zm`e\1;Yp"n2/u
%`Cb8Z.P>(nS
endstream
endobj
20 0 obj
[/Indexed/DeviceRGB 255 19 0 R]
endobj
19 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
85 0 obj
<>
endobj
43 0 obj
<>
endobj
49 0 obj
<>
endobj
40 0 obj
<>
endobj
78 0 obj
<>
endobj
97 0 obj
<>
endobj
39 0 obj
<>
endobj
71 0 obj
<>stream
H{PSwro.(Z_c|-
CD$ o%^Ѣ7qx]-*B,vɒeɑ
q'ˮgklX.NNeljYdɑbidr+Hd
U]L^,Kf%:2J.D&KjN;~1v0&aN$J``1l1I60#ϰLYp'<